RAYMOND JAMES & ASSOCIATES

Holdings History for Aldeyra Therapeutics, Inc. - COM (ALDX)

Symbol: ALDX on Nasdaq
Investment type: Equity - Shares of Stock
Class: COM

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
9/30/2024	0%	+0%	$188K	34.9K	+251	+0.72%	$5.39	Q3 2024
6/30/2024	0%	0%	$115K	34.6K	-1,391	-3.86%	$3.31	Q2 2024
3/31/2024	0%	+0%	$118K	36K	+3,240	+9.88%	$3.27	Q1 2024
12/31/2023	0%	0%	$115K	32.8K	-18,267	-35.8%	$3.51	Q4 2023
9/30/2023	0%	0%	$341K	51.1K	-761	-1.47%	$6.68	Q3 2023
6/30/2023	0%	+0%	$435K	51.8K	+24,970	+93%	$8.39	Q2 2023
3/31/2023	0%	+0%	$267K	26.8K	+1,173	+4.57%	$9.93	Q1 2023
12/31/2022	0%	0%	$179K	25.7K	-1,380	-5.1%	$6.96	Q4 2022
9/30/2022	0%	0%	$144K	27K	-4,177	-13.4%	$5.32	Q3 2022
6/30/2022	0%	+0%	$125K	31.2K	+4,920	+18.7%	$4.00	Q2 2022
3/31/2022	0%	+0%	$117K	26.3K	+4,609	+21.2%	$4.45	Q1 2022
12/31/2021	0%	0%	$87K	21.7K	-24,150	-52.7%	$4.01	Q4 2021
9/30/2021	0%	0%	$403K	45.8K	-495	-1.07%	$8.79	Q3 2021
6/30/2021	0%	+0%	$525K	46.3K	+24,042	+108%	$11.33	Q2 2021
3/31/2021	0%	0%	$265K	22.3K	-498	-2.18%	$11.88	Q1 2021
12/31/2020	0%		$156K	22.8K			$6.84	Q4 2020
9/30/2020	0%	+0%	$169K	22.8K	+698	+3.16%	$7.41	Q3 2020
6/30/2020	0%	0%	$92K	22.1K	-2,500	-10.2%	$4.16	Q2 2020
3/31/2020	0%	+0%	$61K	24.6K	+2,000	+8.85%	$2.48	Q1 2020
12/31/2019	0%	+0%	$131K	22.6K	+400	+1.8%	$5.80	Q4 2019
9/30/2019	0%	+0%	$117K	22.2K	+5,100	+29.8%	$5.27	Q3 2019
6/30/2019	0%	+0%	$103K	17.1K	+17,100	NEW	$6.02	Q2 2019

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.